Precursor Cells, B-Lymphoid < Predictive Value of Tests < Prednisolone

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]

Ident.	Authors (with country if any)	Title
000344 (2019)	Christoph T. Berger [Suisse] ; Birke Rebholz-Chaves [Suisse] ; Mike Recher [Suisse] ; Tobias Manigold [Suisse] ; Thomas Daikeler [Suisse]	Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
000545 (2019)	Jumpei Saito [Japon] ; Naho Yakuwa [Japon] ; Kayoko Kaneko [Japon] ; Ken Nakajima [Japon] ; Chinatsu Takai [Japon] ; Mikako Goto [Japon] ; Akimasa Yamatani [Japon] ; Atsuko Murashima [Japon]	Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis.
000551 (2019)	Sezgin Sahin [Turquie] ; Duhan Hopurcuoglu [Turquie] ; Sule Bektas [Turquie] ; Ezgi Belhan [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Nur Canpolat [Turquie] ; Salim Caliskan [Turquie] ; Lale Sever [Turquie] ; Ozgur Kasapcopur [Turquie]	Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
000722 (2018)	Michael Czihal [Allemagne] ; Christian Lottspeich [Allemagne] ; Angelika Schröttle [Allemagne] ; Karla Maria Treitl [Allemagne] ; Marcus Treitl [Allemagne] ; Jan Leipe [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Ulrich Hoffmann [Allemagne] ; Claudia Dechant [Allemagne]	Relapses in three patients with Takayasu arteritis under tocilizumab treatment detected by contrast enhanced ultrasound.
000801 (2018)	Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Pascal H P. De Jong [Pays-Bas] ; Johanna M W. Hazes [Pays-Bas] ; Angelique E A M. Weel [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]	Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
000824 (2018)	Ying-Chou Chen [Taïwan] ; Wen-Chan Chiu [Taïwan] ; Fu-Mei Su [Taïwan] ; Jia-Feng Chen [Taïwan]	Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
000856 (2018)	Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis]	Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
000A70 (2017)	Muznay N. Khawaja [États-Unis] ; Martin J. Bergman [États-Unis] ; Jeffrey Yourish [États-Unis] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Edward Keystone [Canada]	Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
000C47 (2017)	Takeo Isozaki ; Shinichiro Nishimi ; Airi Nishimi ; Mayu Saito ; Yusuke Miwa ; Yoichi Toyoshima [Japon] ; Katsunori Inagaki [Japon] ; Tsuyoshi Kasama	A disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis.
000C51 (2017)	Worawit Louthrenoo [Thaïlande] ; Nuntana Kasitanon [Thaïlande] ; Wanruchada Katchamart [Thaïlande] ; Duangkamol Aiewruengsurat [Thaïlande] ; Parawee Chevaisrakul [Thaïlande] ; Praveena Chiowchanwisawakit [Thaïlande] ; Pornchai Dechanuwong [Thaïlande] ; Punchong Hanvivadhanakul [Thaïlande] ; Ajanee Mahakkanukrauh [Thaïlande] ; Siriporn Manavathongchai [Thaïlande] ; Chayawee Muangchan [Thaïlande] ; Pongthorn Narongroeknawin [Thaïlande] ; Veerapong Phumethum [Thaïlande] ; Boonjing Siripaitoon [Thaïlande] ; Anawat Suesuwan [Thaïlande] ; Siraphop Suwannaroj [Thaïlande] ; Parichat Uea-Areewongsa [Thaïlande] ; Sittichai Ukritchon [Thaïlande] ; Paijit Asavatanabodee [Thaïlande] ; Ajchara Koolvisoot [Thaïlande] ; Ratanavadee Nanagara [Thaïlande] ; Kitti Totemchokchyakarn [Thaïlande] ; Kanokrut Nuntirooj [Thaïlande] ; Tasanee Kitumnuaypong [Thaïlande]	2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
000D70 (2016)	Alejandro Souto [Oman] ; José Ram N Maneiro ; Juan J. G Mez-Reino [Espagne]	Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases.
000D88 (2016)	Bart V J. Cuppen [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Jan J. Sprengers [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Anne C A. Marijnissen [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Sandhya C. Nair [Pays-Bas]	Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability.
000E21 (2016)	Tadashi Okano [Japon] ; Kentaro Inui [Japon] ; Masahiro Tada [Japon] ; Yuko Sugioka [Japon] ; Kenji Mamoto [Japon] ; Shigeyuki Wakitani [Japon] ; Tatsuya Koike [Japon] ; Hiroaki Nakamura [Japon]	Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
000E22 (2016)	William G. Reiss [États-Unis] ; Jenny N. Devenport [États-Unis] ; Jason M. Low [États-Unis] ; George Wu [États-Unis] ; Eric H. Sasso [États-Unis]	Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
000E36 (2016)	Aurélie De Groof [Belgique] ; Julie Ducreux [Belgique] ; Frances Humby [Royaume-Uni] ; Adrien Nzeusseu Toukap [Belgique] ; Valérie Badot [Belgique] ; Costantino Pitzalis [Royaume-Uni] ; Frédéric A. Houssiau [Belgique] ; Patrick Durez [Belgique] ; Bernard R. Lauwerys [Belgique]	Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy.
000E45 (2016)	Mar Maldonado-Montoro [Espagne] ; Marisa Ca Adas-Garre [Espagne] ; Alfonso González-Utrilla [Espagne] ; José Cristian Plaza-Plaza [Chili] ; Miguel Ngel Calleja-Hernández [Espagne]	Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.
000E73 (2016)	Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Anne Sofie Siebuhr [Danemark] ; Claus Christiansen [Danemark] ; Inger Byrjalsen [Danemark] ; Morten A. Karsdal [Danemark]	Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study.
000F31 (2016)	Yasuyuki Kobayashi [Japon] ; Hitomi Kobayashi [Japon] ; Jon T. Giles [États-Unis] ; Masaharu Hirano [Japon] ; Yasuo Nakajima [Japon] ; Masami Takei [Japon]	Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging.
001021 (2015)	Takeshi Suzuki [Japon] ; Tomoya Hirota ; Hiroshi Ogishima ; Naoto Umeda ; Yuya Kondo ; Masahiro Yokosawa ; Haruka Miki ; Hiroto Tsuboi ; Isao Matsumoto ; Takayuki Sumida	Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
001120 (2015)	Maxime Dougados [France] ; Tom W J. Huizinga [Pays-Bas] ; Ernest H. Choy [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Maher Aassi [Suisse] ; Corrado Bernasconi [Suisse]	Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial.
001142 (2015)	Helena Forsblad-D'Elia [Suède] ; Karin Bengtsson [Suède] ; Lars Erik Kristensen [Suède] ; Lennart T H. Jacobsson [Suède]	Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Predictive Value of Tests" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Predictive Value of Tests" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Predictive Value of Tests
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021